VEA
PGEN icon

Virtus ETF Advisers’s Precigen PGEN Stock Holding History

Virtus ETF Advisers’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-54,216
Closed -$51.3K – 495
2024
Q3 		$51.3K Buy
54,216
+966
+2% +$1.22K 0.02% 441
2024
Q2 		$84.1K Sell
53,250
-15,514
-23% -$22.5K 0.04% 384
2024
Q1 		$99.7K Sell
68,764
-4,713
-6% -$6.77K 0.05% 365
2023
Q4 		$98.5K Sell
73,477
-6,277
-8% -$7.38K 0.06% 366
2023
Q3 		$113K Sell
79,754
-7,938
-9% -$11.3K 0.07% 324
2023
Q2 		$101K Buy
87,692
+28,522
+48% +$33.7K 0.06% 376
2023
Q1 		$62.7K Sell
59,170
-22,742
-28% -$32.8K 0.03% 420
2022
Q4 		$125K Sell
81,912
-3,706
-4% -$6.37K 0.07% 408
2022
Q3 		$182K Buy
85,618
+618
+0.7% +$1.3K 0.07% 329
2022
Q2 		$114K Buy
85,000
+41,072
+93% +$60.9K 0.04% 398
2022
Q1 		$93K Sell
43,928
-2,603
-6% -$6.34K 0.04% 314
2021
Q4 		$173K Buy
46,531
+16,382
+54% +$70.5K 0.07% 270
2021
Q3 		$150K Sell
30,149
-1,580
-5% -$9.1K 0.07% 341
2021
Q2 		$207K Sell
31,729
-798
-2% -$5.58K 0.09% 321
2021
Q1 		$224K Buy
32,527
+565
+2% +$4.78K 0.09% 309
2020
Q4 		$326K Buy
+31,962
New +$207K 0.14% 187

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's PGEN Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Precigen (PGEN) in Q4 2024, closing a stake of 54,216 shares — an estimated $51.3K sold.

Virtus ETF Advisers first reported a position in PGEN in Q4 2020 and held it in 16 quarters. The position peaked at $326K in Q4 2020. 133 funds tracked by Wall St. Rank hold PGEN as of Q4 2024.

  • Virtus ETF Advisers reported no remaining Precigen position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 54,216 Precigen shares in Q4 2024, an estimated $51.3K.
  • Virtus ETF Advisers first reported a position in Precigen in Q4 2020 and held it in 16 quarters.
  • Virtus ETF Advisers's Precigen position peaked at $326K in Q4 2020.
  • 133 funds tracked by Wall St. Rank held Precigen as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.